Pre-conditioning protection in the brain

T W Stone¹

Affiliations

Comment

T W Stone. Br J Pharmacol. 2003 Sep.

. 2003 Sep;140(2):229-30.

doi: 10.1038/sj.bjp.0705441. Epub 2003 Aug 11.

T W Stone¹

¹ Institute of Biomedical and Life Sciences, West Medical Building, University of Glasgow, Glasgow G12 8QQ, U.K. t.w.stone@bio.gla.ac.uk

No abstract available

Comment on

Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.
Pugliese AM, Latini S, Corradetti R, Pedata F. Pugliese AM, et al. Br J Pharmacol. 2003 Sep;140(2):305-14. doi: 10.1038/sj.bjp.0705442. Epub 2003 Aug 11. Br J Pharmacol. 2003. PMID: 12970092 Free PMC article.

1. ADDAE J.I., EVANS S.M., ALI N., STONE T.W. NMDA-induced changes in a cortical network in vivo are prevented by AMPA. Brain Res. 2000;869:211–215. - PubMed
1. ADDAE J.I., STONE T.W. Effects of topically applied excitatory amino acids on evoked potentials and single cell activity in rat cerebral cortex. Eur. J. Pharmacol. 1986;121:337–343. - PubMed
1. BOND A., LODGE D., HICKS C.A., WARD M.A., O'NEILL M.J. NMDA receptor antagonism, but not AMPA antagonism, attenuates ischaemic tolerance in the gerbil hippocampus. Eur. J. Pharmacol. 1999;380:91–99. - PubMed
1. JONES P.A., SMITH R.A., STONE T.W. Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists. Neuroscience. 1998;85:229–237. - PubMed
1. KHASPEKOV L., SHAMLOO L., VICTOROV I., WIELOCH T. Sublethal in vitro glucose–oxygen deprivation protects cultured hippocampal neurons against a subsequent severe insult. Neuroreport. 1998;9:1273–1276. - PubMed